Pulse Brain · Growing Health Evidence Index
Peer-reviewed

Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial

Guillaume Favre, Benedetta Guani, Vincent Balaya, Laurent Magaud, Fabrice Lécuru, Patrice Mathevet

Frontiers in Oncology · 2021

Read source ↗ All evidence

Summary

This randomized study confirmed the results of the Senticol 1 study and supports the sentinel lymph node (SLN) technique as a safe technique for use in patients with early-stage cervical cancer treated with SLNB only. Disease-free survival after 4 years was similar in patients treated with SLN biopsy and patients who underwent a lymphadenectomy.

Source type
Peer-reviewed study
DOI
10.3389/fonc.2020.621518
Catalogue ID
SNmoef2a59-q2lx70
Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.

How does this finding apply in a UK context?→What are the most cited records on this topic?→